NRG THERAPEUTICS LTD

CB1 8PP (East of England)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£1,876,420

Apr 22 - Jul 24

Development of Mitochondrial Permeability Transition Pore Inhibitors for the Treatment of Neurodegenerative Diseases

Innovate UK award to NRG THERAPEUTICS LTD and Richard Rutter

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}